Rare diseases
Investigational molecules
Locations
4 Traverse Dupont, 06130 Grasse, France
Tarian Pharma’s clinical programme includes research on EGFR inhibitor-induced folliculitis, with a focus on skin reactions affecting the face and chest in patients receiving anti-EGFR treatment.
The sponsor’s work in this area is centred on supportive care for patients with treatment-related skin inflammation.
Tarian Pharma runs clinical trials in conditions such as Neuropathy peripheral, Drug eruption, Palmar-plantar erythrodysaesthesia syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of brimonidine tartrate gel to prevent nerve damage in breast cancer patients receiving taxane treatment
FranceTitle: Study of TAR-0520 gel for skin rash (folliculitis) caused by cancer treatment with EGFR inhibitors in colorectal cancer patients
FranceA study to evaluate the safety of brimonidine tartrate gel in preventing hand and foot syndrome in patients with colorectal or breast cancer treated with capecitabine
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
